Reuters logo
BRIEF-AstraZeneca CEO still sees 2023 sales above $40 billion at today's FX
November 9, 2017 / 10:06 AM / a month ago

BRIEF-AstraZeneca CEO still sees 2023 sales above $40 billion at today's FX

Nov 9 (Reuters) - AstraZeneca CEO Pascal Soriot told reporters:

* working to duplicate quality control systems so can release drugs in EU if hard Brexit

* sees high growth rate in China sustainable for next 2-3 years

* long term plan confirms we can get to $40-41 billion sales target by 2023 at current exchange rates Further company coverage: (Reporting by Ben Hirschler)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below